Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2002-01-14
2008-10-14
Hui, San-ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
C514S458000, C514S558000, C514S725000, C424S059000
Reexamination Certificate
active
07435725
ABSTRACT:
An oral composition for the prevention, reduction or treatment of radiation injury including one or more compounds that regulates cell differentiation and/or cell proliferation, and one or more antioxidants, optionally formulated in a pharmaceutically acceptable carrier for an oral composition. The composition of the present invention may further include optional ingredients such as flavonoids, flavonoid derivatives, selenium, selenium compounds, anti-inflammatories, organic germanium, Korean ginseng, American ginseng, Siberian ginseng and B-complex vitamins. A method for the administration of an oral composition for the purpose of preventing, reducing or treating radiation injury involves orally administering an effective amount of a composition including one or more compounds that regulates cell differentiation and/or cell proliferation, and one or more antioxidants to a person before, during or after radiation exposure. The compositions and methods can be employed to prevent, reduce or treat radiation injury caused by a wide variety of types of radiation exposure.
REFERENCES:
patent: 4147795 (1979-04-01), Sarges
patent: 4210667 (1980-07-01), Sarges et al.
patent: 4232040 (1980-11-01), Waterbury
patent: 4250097 (1981-02-01), Pfister
patent: 4617187 (1986-10-01), Okuyama et al.
patent: 4627973 (1986-12-01), Moran et al.
patent: 4822816 (1989-04-01), Markham
patent: 5011840 (1991-04-01), Sarges et al.
patent: 5070085 (1991-12-01), Markham
patent: 5141741 (1992-08-01), Ishida et al.
patent: 5446034 (1995-08-01), Bretting et al.
patent: 5550249 (1996-08-01), Della Valle et al.
patent: 5561110 (1996-10-01), Michaelis et al.
patent: 5571441 (1996-11-01), Andon et al.
patent: 5595982 (1997-01-01), Harless
patent: 5614224 (1997-03-01), Womack
patent: 5648083 (1997-07-01), Blieszner et al.
patent: 5650137 (1997-07-01), Nguyen et al.
patent: 5665360 (1997-09-01), Mann
patent: 5686082 (1997-11-01), N'Guyen
patent: 5709868 (1998-01-01), Perricone
patent: 5776460 (1998-07-01), Kim et al.
patent: 5804168 (1998-09-01), Murad
patent: 5824666 (1998-10-01), Deckner et al.
patent: 5840736 (1998-11-01), Zelle et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 5872140 (1999-02-01), Hesse et al.
patent: 5876737 (1999-03-01), Schonrock et al.
patent: 5883086 (1999-03-01), Craft
patent: 5895652 (1999-04-01), Giampapa et al.
patent: 5922335 (1999-07-01), Ptchelintsev
patent: 5948443 (1999-09-01), Riley et al.
patent: 5952391 (1999-09-01), Gers-Barlag et al.
patent: 5958379 (1999-09-01), Regenold et al.
patent: 5972359 (1999-10-01), Sine et al.
patent: 5972999 (1999-10-01), Murad
patent: 5976568 (1999-11-01), Riley
patent: 5976579 (1999-11-01), McLean
patent: 5981594 (1999-11-01), Okamoto et al.
patent: 5998394 (1999-12-01), Voorhees et al.
patent: 6048886 (2000-04-01), Neigut
patent: 6051602 (2000-04-01), Bissett
patent: 6054128 (2000-04-01), Wakat
patent: 6069168 (2000-05-01), Horrobin et al.
patent: 6162801 (2000-12-01), Kita
patent: 6207656 (2001-03-01), Carswell et al.
patent: 6296861 (2001-10-01), Perricone
patent: 6299896 (2001-10-01), Cooper et al.
patent: 6555573 (2003-04-01), Rosenbloom
patent: 6592896 (2003-07-01), Rosenbloom
patent: 6596313 (2003-07-01), Rosenbloom
patent: 0511895 (1992-11-01), None
patent: 6 199 646 (1994-07-01), None
patent: 07324037 (1995-12-01), None
patent: 11 139 959 (1999-05-01), None
patent: 19910008661 (1993-09-01), None
patent: WO 97/18817 (1997-05-01), None
patent: WO 9718817 (1997-05-01), None
patent: 0000162 (1998-06-01), None
patent: WO 01/17484 (2001-03-01), None
patent: 0137788 (2001-05-01), None
Hardman et al. “Goodman & Gilman's The Pharmaceological Basis of Therapeutics” (9th ed, 1996) p. 51 and 57-58.
Reuters, OncoLink—University of Pennsylvania Cancer Center, “OncoLink Cancer News”, “Burn Cream Reduces Skin Toxicity During Radiation Therapy for Breast Cancer”, Sep. 22, 2000 2pgs.
“A Fact Sheet on the Health Effects from Ionizing Radiation”, Office of Radiation & Indoor Air Radiation Protection Division, US Environmental Protection Agency, EPA 402-F-98-010, May 1998.
Joseph F. Weiss, “Pharmacologic Approaches to Protectionagainst Radiation-induced Lethality and Other Damage”,Public Health Reviews24(3-4):205-431 (1996) Abstract.
Ishige, et al., “Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms”,Fee Radic Biol Med 2001Feb. 15;30 Abstract.
Wang, “The therapeutic potential of flavonoids”,Expert Opin Investig Drugs Sep. 2000;9(9): 2103-19 Abstract.
Klimenko et al., “The blood kinin system of person swith a history of 1st-degree acture radiation sickness”,Lik SpravaMay -Jun. 1994;(5-6:81-3 Abstract.
Wadsworth et al., “Effects of Ginko biloba extract (Egb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha”,Biochem PharmacolOct. 1, 2001;62, Abstract.
Kapoor S., “Protection of radiation-induced protein damage by curcumin”,Biophys ChemAug. 30, 2001;92(1-2):119-26 Abstract.
Inano et al., “Potent preventive action of curcumin on radiation—induced initation of mammary tumorigenesis in rats”,CarcinogenesisOct. 2000;21(10): 1835-45 Abstract.
Sharma et al., “Sprice extracts as dose-modifying factors in radiationinactivation of bacteria”,J Agric Food ChemApr. 2000;48(4):1340-4 Abstract.
Strickland, “Immune regulation by polysaccharides: implications for skin cancer”, J. Photochem Photobiol B Oct. 2001;63(1-3):132-40 Abstract.
Gessler, et al. “Radiation-protective effect of S-methylmethionine (vitamin U)”,Prikl Biokhim MikrobiolNov.-Dec. 1996;32 (6):666-8 Abstract.
Nagler, et al., “Redox metal chelation ameliorates radiation-induced bone marrow toxicity in a mouse model”,Radiat ResAug. 2001; 156(2):205-9 Abstract.
Horyn et al., “The effect of sodium alpha-ketoglutarate on the indices of the peripheral blood and lipid peroxidation and on the enzyme activity of antioxidant protection in irradiated rats”Fizol Zh2000;46(3):57-66.
Legeza, et al., “Prostaglandins—their role in the mechanisms of the development of the primary reaction to radiationsyndrome”,Radiats Biol RadioecolJan.-Feb. 1994;34(1):32-8.
Novozhenov, et al., “Changes in lipid peroxidation and the antioxidant system in patients with acute radiation sickness”,Voen Med ZhApr. 1993;(4):38-40, 80 Abstract.
Chaialo, et al., “Free-radical processes and blood antioxidant systems in the late period following acute radiation sickness”,Med Radiol(Mosk) 1991;36(5):20-1 Abstract.
Bazhan, “Lipid peroxidation and the antioxidant system in subjects exposed to the influence of extreme factors”,Lik SpravaDec. 1998;(8):47-50 Abstract.
Beckman, et al., “Radiation therapy impairs endothelium-dependent vasodilation in humans”,J Am Coll CardiolMar. 1, 2001;37(3):761 Abstract.
Castillo, et al., “Antiosidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (Procyanidins) from grape seeds (Vitis vinifera): comparative study versus other phenolic and organic compounds”,J Agric Food ChemMay 2000;48(5):1738-45 Abstract.
Weiss, et al., “Radioprotection by antioxidants”,Ann N Y Acad Sci2000;899:44-60 Abstract.
Weiss, “Pharmacologic approaches to protection against radiation-induced lethality and other damage”,Environ Health PerspectDec. 1997;105 Suppl6:1473-8 Abstract.
Baraboi, et al., “Mechanism of the antistressor and antiradiation action of plant phenol compounds”,Ukr Biokhim ZhNov.-Dec. 1998;70(6):13-23 Abstract.
Wu, et al., “Synthesis and bio-activity of coumarin derivatives and studies on its relationships between activity and lipophilicity”,Yao Xue Xue Bao1993;28(4):266-72 Abstract.
Thresiamma, et al., “Protective effect of curcumin, ellagic acid and bixin on radiation
Hui San-ming
Knoble & Yoshida & Dunleavy LLC
The Quigly Corporation
LandOfFree
Oral compositions and methods for prevention, reduction and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral compositions and methods for prevention, reduction and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral compositions and methods for prevention, reduction and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4003736